X4 Pharmaceuticals

XFOR · NASDAQ

$3.02+$0.27 (+9.82%)TodayMarket closed ·
Prev close $2.75

Who owns XFOR

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 69.9% of XFOR’s shares.

  • Morgan Stanley Investment Management Inc. (US)10.0%
  • Fidelity Management & Research Company LLC8.8%
  • Bain Capital Life Sciences Investors, LLC8.4%
  • Perceptive Advisors LLC8.4%
  • Next 6 largest institutions34.3%
  • All other shareholders30.1%
Top institutional holders of XFOR
HolderShares% of shares
Morgan Stanley Investment Management Inc. (US)9.42M9.99%
Fidelity Management & Research Company LLC8.32M8.82%
Bain Capital Life Sciences Investors, LLC7.97M8.45%
Perceptive Advisors LLC7.93M8.41%
Saturn V Capital Management LP6.97M7.39%
Empery Asset Management, L.P.6.93M7.35%
Deep Track Capital LP5.88M6.23%
BlackRock Institutional Trust Company, N.A.5.10M5.41%
Kalehua Capital Management LLC3.72M3.95%
Vanguard Capital Management, LLC3.72M3.94%

Largest mutual fund holders

Top mutual fund holders of XFOR
HolderShares% of shares
Fidelity Small Cap Growth Fund3.39M3.59%
Vanguard Total Stock Market Index Fund2.60M2.76%
Morgan Stanley Institutional Small Co. Inception Portfolio2.31M2.45%
iShares Russell 2000 ETF1.98M2.10%
Fidelity Small Cap Growth K6 Fund1.69M1.79%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders sold $462.96K (5 trades) of XFOR on the open market, with no buys.

Latest XFOR insider transactions
InsiderTypeSharesValue
KIRSKE DAVIDSale11.77K$33.66K
Volpone JohnSale24.58K$109.23K
Craig Adam RSale47.44K$210.83K
Gold KellyAward110.00K—
KIRSKE DAVIDSale8.54K$36.43K
KIRSKE DAVIDSale16.96K$72.82K

Short interest

Settled Sep 30, 2026

Shares short
7.59M
Days to cover
6.04
% of shares outstanding
8.05%
Average daily volume
1.26M
Change since last report
−7.8%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.